BLISS GVS PHARMA Q2 FY27 ; NET PROFIT UP 87% AT ₹53 CR (YOY), UP 4% (QOQ)

REVENUE UP 4% AT ₹313 CR (YOY), UP 10% (QOQ) EBITDA UP 79% AT ₹79 CR (YOY), UP 3% (QOQ) MARGINS AT 25.1% VS 14.6% (YOY), 26.8% (QOQ)

BLISS GVS PHARMA LTD.